You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
24 January 2022
Procter & Gamble (P&G) is increasing the prices of some of its Personal Health Care brands in the US with effect from mid-April 2022. The announcement came as the company said its Personal Health Care business had recorded worldwide sales up by around 20% on an organic basis in the three months ende...
22 October 2021
Procter & Gamble (P&G) said worldwide sales at its Personal Health Care business had increased by "double-digits" on an organic basis in the three months ended 30 September 2021.
3 August 2021
Procter & Gamble (P&G) is expecting a USD1.9 billion headwind from rising commodity and freight costs in the 12 months ended 30 June 2022. Chief financial officer Andre Schulten says the company is considering additional price increases on top of those already announced.
30 July 2021
Procter & Gamble (P&G) has announced that its chief operating officer Jon Moeller will take over as president and chief executive officer with effect from 1 November 2021.
30 June 2021
Procter & Gamble (P&G) Personal Health Care is building on its global nerve care expertise by launching a range of dietary supplements in the US under the new brand name Nervive.
22 April 2021
Procter & Gamble (P&G) said worldwide sales at its Personal Health Care business had decreased by "mid-single-digits" on an organic basis in the three months ended 31 March 2021. The company has announced plans to introduce significant price increases for its Baby Care, Feminine Care and Adult Incon...
14 April 2021
Procter & Gamble (P&G) has strengthened its presence in Australia by acquiring effervescent specialist Voost Vitamins for an undisclosed sum.
21 January 2021
Procter & Gamble (P&G) said the Merck Consumer Health business acquired in 2018 had achieved “high teens” sales growth in the three months ended 31 December 2020.
12 January 2021
Procter & Gamble (P&G) has abandoned its proposed acquisition of Billie, AFT Pharmaceuticals’ Maxigesic pain reliever has been launched in Canada as Combogesic, and Sanofi has revealed the name and chief of its proposed active pharmaceutical ingredients (API) company.